Preparation, Characterization and Evaluation of Albendazole Loaded Solid Lipid Nanoparticles from Beeswax for Screening of its Anti-Helminthic and Anti-Cancer Properties

dc.contributor.authorSharma, Sunidhi
dc.contributor.supervisorChoudhury, Diptiman
dc.date.accessioned2019-09-10T11:22:35Z
dc.date.available2019-09-10T11:22:35Z
dc.date.issued2019-09-10
dc.description.abstractSLNs are the non-toxic, biodegradable, nanospheres with a solid lipid matrix that are being employed for targeted drug delivery applications. These particles have shown sustained drug release pattern and are known to improve the aqueous solubility of hydrophobic drugs. In the present study, Albendazole drug, known for its poor water solubility, was loaded in SLN particles that were produced using the methanol extract derived from the beeswax and checked for its effects on the helminthic worm Haemonchous contortus and lung cancer cell line A549. In-vitro studies on A549 cell line was done to examine the cytotoxicity of these particles against the cancer cell line and it was found to be more toxic when Albendazole drug was loaded in the particles than in comparison to the SLN particles (without drug). DLS was used to determine the size of these particles and FT-IR and RAMAN spectrum were studied for confirmation of formation of SLN-Abz particles.en_US
dc.identifier.urihttp://hdl.handle.net/10266/5759
dc.language.isoenen_US
dc.subjectsolid lipid nanoparticlesen_US
dc.subjectbeeswaxen_US
dc.subjectalbendazoleen_US
dc.subjecthaemonchous contortus wormen_US
dc.subjectA549 cancer cell lineen_US
dc.titlePreparation, Characterization and Evaluation of Albendazole Loaded Solid Lipid Nanoparticles from Beeswax for Screening of its Anti-Helminthic and Anti-Cancer Propertiesen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sunidhi.pdf
Size:
1.98 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.03 KB
Format:
Item-specific license agreed upon to submission
Description: